** Shares of Imagion Biosystems Ltd IBX.AX rise as much as
24% to A$0.031 - set for best day since July 5, if gains hold
** Healthcare co announces interim data from its Phase I
study of breast cancer imaging agent
** Says results suggest molecular signature of the imaging
agent could help discriminate potentially cancerous nodes from
normal nodes when used with conventional MRI in patients
** Shares of co hit their highest since Oct 26
** More than 12.31 mln shares change hands, compared with
the 30-day average trading volume of 1.18 mln shares
** Shares down 67.1% YTD, as of last close
(Reporting by John Biju in Bengaluru)
((John.Biju@thomsonreuters.com;))